• On October 14, 2025, DENTSPLY SIRONA announced that the SEC concluded its investigation into the company’s financial reporting matters without recommending any enforcement action.
• This resolution eliminates a major regulatory overhang and signals that DENTSPLY SIRONA's cooperation and internal review effectively addressed concerns raised during the inquiry.
• We’ll explore how the removal of this regulatory uncertainty could influence DENTSPLY SIRONA’s forward-looking investment narrative and risk profile.

Explore 27 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

DENTSPLY SIRONA Investment Narrative Recap

To own DENTSPLY SIRONA shares, you need to see long-term promise in the company’s ability to reverse softening sales and margin pressures through product innovation and operational streamlining. The recent conclusion of the SEC investigation removes a major regulatory cloud, but the most important near-term catalyst, reigniting sustainable top-line growth, remains unaddressed, while persistent weakness in global sales continues to be the core risk for investors following this event.

The recent announcement to voluntarily suspend Byte Aligners and Impression Kits reflects ongoing responses to changing regulatory and compliance demands, highlighting how DENTSPLY SIRONA’s current growth headwinds are closely tied to both market and legal developments. Until meaningful traction on revenue recovery is evident, investor focus is likely to stay on execution and margin protection efforts, key areas affected by operational and regulatory challenges.

However, investors should be aware that one ongoing risk could still threaten the recovery story...

DENTSPLY SIRONA is projected to reach $3.9 billion in revenue and $502.2 million in earnings by 2028. This outlook is based on an assumed 2.3% annual revenue growth and a $1.45 billion increase in earnings from the current level of -$949.0 million.

Uncover how DENTSPLY SIRONA's forecasts yield a $16.43 fair value, a 27% upside to its current price.

Exploring Other Perspectives

Simply Wall St Community members have produced three fair value estimates for DENTSPLY SIRONA ranging from US$16.43 to US$34.81 per share. While opinions differ widely, many remain focused on whether the company’s cost headwinds and margin pressures will keep affecting its performance.

Explore 3 other fair value estimates on DENTSPLY SIRONA - why the stock might be worth just $16.43!

Build Your Own DENTSPLY SIRONA Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your DENTSPLY SIRONA research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
• Our free DENTSPLY SIRONA research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate DENTSPLY SIRONA's overall financial health at a glance.

Seeking Other Investments?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

• Find companies with promising cash flow potential yet trading below their fair value.
• The end of cancer? These 28 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
• These 12 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.